Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Pseudomonas aeruginosa keratitis in mice: effects of topical bacteriophage KPP12 administration.

Fukuda K, Ishida W, Uchiyama J, Rashel M, Kato S, Morita T, Muraoka A, Sumi T, Matsuzaki S, Daibata M, Fukushima A.

PLoS One. 2012;7(10):e47742. doi: 10.1371/journal.pone.0047742. Epub 2012 Oct 17.

2.

Corneal response to Pseudomonas aeruginosa infection.

Hazlett LD.

Prog Retin Eye Res. 2004 Jan;23(1):1-30. Review.

PMID:
14766315
3.

Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review.

Willcox MD.

Optom Vis Sci. 2007 Apr;84(4):273-8. Review.

PMID:
17435510
4.

Role of innate and adaptive immunity in the pathogenesis of keratitis.

Hazlett LD.

Ocul Immunol Inflamm. 2005 Apr-Jun;13(2-3):133-8. Review.

PMID:
16019672
5.

[Keratitis associated with contact lens wear].

Mattila JS, Holopainen J.

Duodecim. 2013;129(18):1901-7. Review. Finnish.

PMID:
24187781
6.

Animal models of bacterial keratitis.

Marquart ME.

J Biomed Biotechnol. 2011;2011:680642. doi: 10.1155/2011/680642. Epub 2011 Jan 4. Review.

7.

The pathogenesis of bacterial keratitis: studies with Pseudomonas aeruginosa.

Fleiszig SM, Evans DJ.

Clin Exp Optom. 2002 Sep;85(5):271-8. Review.

8.

Use of bacteriophages in the treatment of Pseudomonas aeruginosa infections.

Soothill J.

Expert Rev Anti Infect Ther. 2013 Sep;11(9):909-15. doi: 10.1586/14787210.2013.826990. Review.

PMID:
24053272
9.

Experimental Pseudomonas keratitis.

Hyndiuk RA.

Trans Am Ophthalmol Soc. 1981;79:541-624. Review. No abstract available.

10.

Therapy of Pseudomonas aeruginosa eye infections.

Thiel HJ, Steuhl KP, Döring G.

Antibiot Chemother (1971). 1987;39:92-101. Review. No abstract available.

PMID:
3314688
11.

[Phagotherapy: a nightmare for bacteria, a dream for physicians?].

Debarbieux L, Saussereau E, Maura D.

Biol Aujourdhui. 2013;207(3):181-90. doi: 10.1051/jbio/2013017. Epub 2013 Dec 13. Review. French.

PMID:
24330971
12.

Bacteriophages in the experimental treatment of Pseudomonas aeruginosa infections in mice.

Saussereau E, Debarbieux L.

Adv Virus Res. 2012;83:123-41. doi: 10.1016/B978-0-12-394438-2.00004-9. Review.

PMID:
22748810
13.

Established and emerging ancillary techniques in management of microbial keratitis: a review.

Robaei D, Carnt N, Watson S.

Br J Ophthalmol. 2016 Sep;100(9):1163-70. doi: 10.1136/bjophthalmol-2015-307371. Epub 2016 Feb 17. Review.

PMID:
26888977
14.

[Steam cautery of the cornea in microbial keratitis].

Maier P, Birnbaum F, Reinhard T.

Ophthalmologe. 2008 Jan;105(1):79-80. Review. German.

PMID:
18008076
15.

IL-10 function, regulation, and in bacterial keratitis.

Hazlett LD, Jiang X, McClellan SA.

J Ocul Pharmacol Ther. 2014 Jun;30(5):373-80. doi: 10.1089/jop.2014.0018. Epub 2014 Apr 16. Review.

16.

Adjunctive Therapies for Bacterial Keratitis.

Dakhil TAB, Stone DU, Gritz DC.

Middle East Afr J Ophthalmol. 2017 Jan-Mar;24(1):11-17. doi: 10.4103/meajo.MEAJO_264_16. Review.

17.

Drugs - Do we need them? Applications of non-pharmaceutical therapy in anterior eye disease: A review.

Mandal P, Khan MA, Shah S.

Cont Lens Anterior Eye. 2017 Dec;40(6):360-366. doi: 10.1016/j.clae.2017.09.001. Epub 2017 Sep 14. Review.

PMID:
28919243
18.

[Therapy and prognosis of bacterial keratitis].

Behrens-Baumann W, Pleyer U.

Ophthalmologe. 2007 Jan;104(1):15-20. Review. German.

PMID:
17216414

Supplemental Content

Support Center